
Nippon Chemiphar, Japan's 100% owend subsidiary, established in 2015, and started commercial manufacturing of pharmaceutical products in 2018, after getting GMP license from PMDA/DAV Vietnam, and EBP from DAV Vietnam-Mission Statement The goal of the Nippon Chemiphar Group is to make a difference in society by providing pharmaceutical drugs and health-related services to help people become and remain healthy. See more about Nippon Chemiphar Group at
Annual Revenue$50M to $100M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.